- Home
- NMRK vs PBH Comparison
NMRK vs PBH Comparison
Compare NMRK & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRK
- PBH
- Stock Information
- Founded
- NMRK 1929
- PBH 1996
- Country
- NMRK United States
- PBH United States
- Employees
- NMRK N/A
- PBH N/A
- Industry
- NMRK Real Estate
- PBH Biotechnology: Pharmaceutical Preparations
- Sector
- NMRK Finance
- PBH Health Care
- Exchange
- NMRK Nasdaq
- PBH Nasdaq
- Market Cap
- NMRK 3.1B
- PBH 2.8B
- IPO Year
- NMRK 2017
- PBH 2005
- Fundamental
- Price
- NMRK $17.53
- PBH $59.83
- Analyst Decision
- NMRK Strong Buy
- PBH Buy
- Analyst Count
- NMRK 5
- PBH 5
- Target Price
- NMRK $19.00
- PBH $86.40
- AVG Volume (30 Days)
- NMRK 1.4M
- PBH 462.7K
- Earning Date
- NMRK 10-30-2025
- PBH 11-06-2025
- Dividend Yield
- NMRK 0.69%
- PBH N/A
- EPS Growth
- NMRK 94.50
- PBH N/A
- EPS
- NMRK 0.59
- PBH 4.04
- Revenue
- NMRK $3,160,782,000.00
- PBH $1,110,479,000.00
- Revenue This Year
- NMRK $19.70
- PBH N/A
- Revenue Next Year
- NMRK $9.58
- PBH $2.69
- P/E Ratio
- NMRK $29.57
- PBH $14.74
- Revenue Growth
- NMRK 20.95
- PBH N/A
- 52 Week Low
- NMRK $9.65
- PBH $57.25
- 52 Week High
- NMRK $19.84
- PBH $90.04
- Technical
- Relative Strength Index (RSI)
- NMRK 53.98
- PBH 47.11
- Support Level
- NMRK $15.29
- PBH $57.25
- Resistance Level
- NMRK $17.61
- PBH $60.35
- Average True Range (ATR)
- NMRK 0.64
- PBH 1.64
- MACD
- NMRK 0.11
- PBH 0.06
- Stochastic Oscillator
- NMRK 94.84
- PBH 50.69
About NMRK Newmark Group Inc.
Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.
About PBH Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.